Taking stock of the drug industry, from the lab to the medicine chestMarch 27, 2023Check out STAT+Sponsored ByBy Ed SilvermanPharmalot Columnist, Senior Writer APStock STAT+ | Ohio attorney general accuses pharmacy benefit managers of drug price fixing The Ohio attorney general filed a lawsuit on Monday accusing three large pharmacy benefit managers of fixing prices on some drugs. By Ed Silverman With arrival of breakthrough therapies, a rare disease group reconsiders the possible — and its mission A new age of genetic medicine is forcing patients and researchers to confront a blessed question: What happens when treatment finally comes? By Jason Mast STAT+ | Under protest, FDA to convene advisory panel to review controversial cell therapy for ALS FDA officials have promised to apply the "broadest regulatory flexibility" to ALS drug reviews, even for therapies with uncertain benefit. By Adam Feuerstein Adobe STAT+ | Wary of changes to Medicare Advantage, health insurers put up a fight — and exaggerate the stakes Insurers are distorting the reality of the proposals in a bid to protect the sizable and growing profits they earn from Medicare Advantage. By Bob Herman Newly available test strips can detect lethal 'tranq' in drug supply The sedative is increasingly common in the U.S. illicit-drug supply — especially in Philadelphia, but increasingly in other cities, too. By Lev Facher More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Pharmalot? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments